AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 37821122 — intervention group
Group type: COMPARATOR
Intervention: Sham lavage plus subacromial injection of 10 mL 1% lidocaine hydrochloride (sham)
Number of subjects: 220
Study 37821122 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 220
Study 37821131 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg potassium canrenoate every 6 hours until organ procurement
Number of subjects: 36
Study 37821131 — intervention group
Group type: COMPARATOR
Intervention: Matching placebo every 6 hours until organ procurement
Number of subjects: 36
Study 37821166 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel monotherapy
Number of subjects: 5403
Study 37821166 — intervention group
Group type: COMPARATOR
Intervention: Aspirin monotherapy
Number of subjects: 5403
Study 37821170 — intervention group
Group type: EXPERIMENTAL
Intervention: Flurpiridaz F-18 PET myocardial perfusion imaging
Number of subjects: 730
Study 37821170 — intervention group
Group type: COMPARATOR
Intervention: Tc-99m-labeled SPECT
Number of subjects: 730
Study 37821242 — intervention group
Group type: EXPERIMENTAL
Intervention: Metastasis-directed therapy (MDT) and 6 months of androgen deprivation therapy (ADT)
Number of subjects: 196
Study 37821242 — intervention group
Group type: COMPARATOR
Intervention: Elective nodal pelvic radiotherapy (ENRT) [25 × 1.8 Gy] with MDT and 6 months of ADT
Number of subjects: 196
Study 37821342 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil infusion at ZT8
Number of subjects: 2
Study 37821342 — intervention group
Group type: EXPERIMENTAL
Intervention: Sufentanil infusion at ZT8
Number of subjects: 2
Study 37821342 — intervention group
Group type: EXPERIMENTAL
Intervention: Afternoon group (patients)
Number of subjects: 2
Study 37821342 — intervention group
Group type: COMPARATOR
Intervention: Morning group (patients)
Number of subjects: 2
Study 37821461 — intervention group
Group type: EXPERIMENTAL
Intervention: Antipsychotics plus metformin
Number of subjects: 72
Study 37821461 — intervention group
Group type: COMPARATOR
Intervention: Antipsychotics alone
Number of subjects: 72
Study 37821472 — intervention group
Group type: EXPERIMENTAL
Intervention: Latency-reversing agent vorinostat, ChAdV63.HIVconsv and MVA.HIVconsv vaccines
Number of subjects: 0
Study 37821472 — intervention group
Group type: COMPARATOR
Intervention: ART alone
Number of subjects: 0
Study 37821876 — intervention group
Group type: EXPERIMENTAL
Intervention: App-based dietary intervention over 12 weeks
Number of subjects: 93
Study 37821876 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 93
Study 37821913 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal intervention based on Cognitive Behavior Therapy
Number of subjects: 880
Study 37821924 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-week co-produced web-based educational programme consisting of 6 modules
Number of subjects: 30
Study 37821924 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 30
Study 37821950 — intervention group
Group type: EXPERIMENTAL
Intervention: Near-infrared spectroscopy (NIRS) measuring skeletal muscle regional tissue oxygenation (rSO2)
Number of subjects: 20
Study 37821950 — intervention group
Group type: EXPERIMENTAL
Intervention: Basal and maximal skeletal muscle rSO2 measurements
Number of subjects: 20
Study 37821968 — intervention group
Group type: EXPERIMENTAL
Intervention: Central venous oxygen saturation (ScvO2)-based goal-directed therapy
Number of subjects: 0
Study 37821968 — intervention group
Group type: COMPARATOR
Intervention: Standard fluid loading-based goal-directed therapy
Number of subjects: 0
Study 37821994 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative multidisciplinary team (MDT) meetings
Number of subjects: 1200
Study 37821994 — intervention group
Group type: COMPARATOR
Intervention: Preoperative screening as usual
Number of subjects: 1200
Study 37822243 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-molecular-weight fucoidan (LMF) as a supplement to therapy.
Number of subjects: 0
Study 37822243 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group).
Number of subjects: 0
Study 37822567 — intervention group
Group type: EXPERIMENTAL
Intervention: Decompressive laparotomy (DL)
Number of subjects: 100
Study 37822567 — intervention group
Group type: COMPARATOR
Intervention: Decompressive craniectomy (DC)
Number of subjects: 100
Study 37822710 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise (60- to 75-min daily)
Number of subjects: 22
Study 37822710 — intervention group
Group type: COMPARATOR
Intervention: Control (inactive)
Number of subjects: 22
Study 37822872 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe periodontitis
Number of subjects: 6209
Study 37822872 — intervention group
Group type: EXPERIMENTAL
Intervention: Log-transformed inflammatory biomarkers IL-6 and hsCRP
Number of subjects: 6209
Study 37823031 — intervention group
Group type: EXPERIMENTAL
Intervention: TransCon CNP 100 μg CNP/kg/week
Number of subjects: 42
Study 37823031 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study 37823034 — intervention group
Group type: EXPERIMENTAL
Intervention: TV-46046 (120 mg/0.3 mL)
Number of subjects: 27
Study 37823034 — intervention group
Group type: COMPARATOR
Intervention: Depo-subQ Provera 104 (104 mg/0.65 mL)
Number of subjects: 27
Study 37823034 — intervention group
Group type: EXPERIMENTAL
Intervention: Diluted TV-46046 (60 mg/0.3 mL)
Number of subjects: 27
Study 37823034 — intervention group
Group type: EXPERIMENTAL
Intervention: TV-46046 placebo (0.3 mL)
Number of subjects: 27
Study 37823469 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic immunosuppression (glucocorticoids or mycophenolate mofetil)
Number of subjects: 0
Study 37823469 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 0
Study 37823469 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucocorticoid treatment
Number of subjects: 0
Study 37823562 — intervention group
Group type: EXPERIMENTAL
Intervention: Music enrichment program
Number of subjects: 32
Study 37823562 — intervention group
Group type: COMPARATOR
Intervention: Playdate control
Number of subjects: 32
Study 37823722 — intervention group
Group type: EXPERIMENTAL
Intervention: Fingolimod treatment
Number of subjects: 324
Study 37823722 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 324
Study 37823729 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonographic measurements of diaphragmatic excursion (DE) and thickening fraction (TF) before anaesthesia induction (T0), 1 h postoperatively (T1), and 24 h postoperatively (T2)
Number of subjects: 74
Study 37823729 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonographic measurements of DE T2 /DE T0 and TF T2 /TF T0
Number of subjects: 74
Study 37823729 — intervention group
Group type: EXPERIMENTAL
Intervention: Receiver operating characteristic analysis of DE T2 /DE T0
Number of subjects: 74
Study 37823892 — intervention group
Group type: EXPERIMENTAL
Intervention: CamAPS FX Hybrid Closed-Loop with Ultra-Rapid Lispro
Number of subjects: 0
Study 37823892 — intervention group
Group type: COMPARATOR
Intervention: Standard Lispro
Number of subjects: 0
Study 37823971 — intervention group
Group type: COMPARATOR
Intervention: Heparin (5000 IU/ml)
Number of subjects: 426
Study 37823971 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate (8.4%)
Number of subjects: 426
Study 37824038 — intervention group
Group type: EXPERIMENTAL
Intervention: Compression sonography of the internal jugular vein (IJVP)
Number of subjects: 10
Study 37824038 — intervention group
Group type: COMPARATOR
Intervention: Invasive measures of central venous pressure (CVP)
Number of subjects: 10
Study 37824131 — intervention group
Group type: EXPERIMENTAL
Intervention: Intratumoral GLA-SE (5 μg and 10 μg for 8 weekly doses) with concurrent radiotherapy
Number of subjects: 12
Study 37824131 — intervention group
Group type: EXPERIMENTAL
Intervention: Intratumoral GLA-SE with concurrent radiotherapy
Number of subjects: 12
Study 37824137 — intervention group
Group type: COMPARATOR
Intervention: Topotecan alone (1.25 mg/m2 intravenously on days 1 through 5)
Number of subjects: 60
Study 37824137 — intervention group
Group type: EXPERIMENTAL
Intervention: Topotecan with berzosertib (210 mg/m2 intravenously on days 2 and 5)
Number of subjects: 60
Study 37824145 — intervention group
Group type: EXPERIMENTAL
Intervention: Video tutorials on managing common symptoms in acutely ill children and when to seek medical help.
Number of subjects: 4686
Study 37824145 — intervention group
Group type: EXPERIMENTAL
Intervention: Video tutorials
Number of subjects: 4686
Study 37824145 — intervention group
Group type: COMPARATOR
Intervention: Telephone triage by a nurse or physician (control)
Number of subjects: 4686
Study 37824152 — intervention group
Group type: EXPERIMENTAL
Intervention: Small-volume tubes
Number of subjects: 21201
Study 37824152 — intervention group
Group type: COMPARATOR
Intervention: Standard-volume tubes
Number of subjects: 21201
Study 37824155 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryoprecipitate (3 pools, 6-g fibrinogen equivalent) administered within 90 minutes of randomization and 3 hours of injury, in addition to standard care.
Number of subjects: 1604
Study 37824155 — intervention group
Group type: COMPARATOR
Intervention: Standard care (local major hemorrhage protocol).
Number of subjects: 1604
Study 37824155 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryoprecipitate group.
Number of subjects: 1604
Study 37824155 — intervention group
Group type: COMPARATOR
Intervention: Standard care group.
Number of subjects: 1604
Study 37824188 — intervention group
Group type: EXPERIMENTAL
Intervention: Real-time seat interface pressure mapping feedback
Number of subjects: 23
Study 37824188 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard PI prevention education + Real-time seat interface pressure mapping feedback
Number of subjects: 23
Study 37824188 — intervention group
Group type: COMPARATOR
Intervention: Standard PI prevention education
Number of subjects: 23
Study 37824197 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive test scores (Montreal Cognitive Assessment, Trail Making Test, Digit Symbol Substitution Test, forward and backward digit span testing)
Number of subjects: 100
Study 37824197 — intervention group
Group type: EXPERIMENTAL
Intervention: Depression, stress, and anxiety screening
Number of subjects: 100
Study 37824197 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum levels of biomarkers (SAA, Hcy, S100B, BDNF)
Number of subjects: 100
Study 37824197 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls (HC)
Number of subjects: 100
Study 37824257 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational enhancement therapy (MET)
Number of subjects: 161
Study 37824257 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 161
Study 37824436 — intervention group
Group type: EXPERIMENTAL
Intervention: Dural puncture epidural (DPE) technique
Number of subjects: 100
Study 37824436 — intervention group
Group type: COMPARATOR
Intervention: Conventional epidural (EPL) technique
Number of subjects: 100
Study 37824754 — intervention group
Group type: EXPERIMENTAL
Intervention: Art Therapy
Number of subjects: 0
Study 37824754 — intervention group
Group type: COMPARATOR
Intervention: Control (standard care)
Number of subjects: 0
Study 37826937 — intervention group
Group type: EXPERIMENTAL
Intervention: 45 mg caffeine
Number of subjects: 45
Study 37826937 — intervention group
Group type: EXPERIMENTAL
Intervention: 120 mg caffeine
Number of subjects: 45
Study 37826937 — intervention group
Group type: COMPARATOR
Intervention: No caffeine
Number of subjects: 45
Study 37826992 — intervention group
Group type: EXPERIMENTAL
Intervention: Walnut-enriched diet (WD)
Number of subjects: 35
Study 37826992 — intervention group
Group type: COMPARATOR
Intervention: Fatty acid-matched diet devoid of walnuts (WFMD)
Number of subjects: 35
Study 37826992 — intervention group
Group type: COMPARATOR
Intervention: Diet where oleic acid replaces alpha-linolenic acid (ORAD)
Number of subjects: 35
Study 37827268 — intervention group
Group type: EXPERIMENTAL
Intervention: Cabergoline (1 mg once on postpartum day 1 or 0.25 mg twice a day for 2 days)
Number of subjects: 88
Study 37827268 — intervention group
Group type: COMPARATOR
Intervention: Pyridoxine (200 mg 3 times a day for 7 days)
Number of subjects: 88
Study 37827268 — intervention group
Group type: EXPERIMENTAL
Intervention: Cabergoline
Number of subjects: 88
Study 37827268 — intervention group
Group type: COMPARATOR
Intervention: Pyridoxine
Number of subjects: 88
Study 37827280 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostate (bed) only radiotherapy (PBRT)
Number of subjects: 50
Study 37827280 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole pelvis radiotherapy (WPRT)
Number of subjects: 50
Study 37827280 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy
Number of subjects: 50
Study 37827280 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline α-diversity
Number of subjects: 50
Study 37827280 — intervention group
Group type: EXPERIMENTAL
Intervention: Metabolic fingerprint
Number of subjects: 50
Study 37827280 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiation dose and treatment volume
Number of subjects: 50
Study 37827280 — intervention group
Group type: EXPERIMENTAL
Intervention: Toxicity risk stratification tools
Number of subjects: 50
Study 37827557 — intervention group
Group type: EXPERIMENTAL
Intervention: UK HFpEF Registry
Number of subjects: 0
Study 37827573 — intervention group
Group type: EXPERIMENTAL
Intervention: Face masks
Number of subjects: 0
Study 37827573 — intervention group
Group type: COMPARATOR
Intervention: No face masks
Number of subjects: 0
Study 37827738 — intervention group
Group type: EXPERIMENTAL
Intervention: Questionable health behaviours assessment
Number of subjects: 1043
Study 37827738 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological predictors assessment
Number of subjects: 1043
Study 37827744 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-led home-based surveillance after curative CRC treatment.
Number of subjects: 0
Study 37828033 — intervention group
Group type: EXPERIMENTAL
Intervention: Sintilimab (anti-PD-1) at doses of 1, 3, and 10 mg/kg
Number of subjects: 29
Study 37828033 — intervention group
Group type: EXPERIMENTAL
Intervention: Sintilimab (anti-PD-1)
Number of subjects: 29
Study 37828034 — intervention group
Group type: EXPERIMENTAL
Intervention: ZSP1601 50 mg once daily
Number of subjects: 36
Study 37828034 — intervention group
Group type: EXPERIMENTAL
Intervention: ZSP1601 50 mg twice daily
Number of subjects: 36
Study 37828034 — intervention group
Group type: EXPERIMENTAL
Intervention: ZSP1601 100 mg twice daily
Number of subjects: 36
Study 37828034 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 37828071 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes mellitus severity and treatment regimen (oral medication vs insulin vs both oral + insulin)
Number of subjects: 881
Study 37828071 — intervention group
Group type: EXPERIMENTAL
Intervention: Metabolic control reflected by HbA1c levels
Number of subjects: 881
Study 37828071 — intervention group
Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 881
Study 37828071 — intervention group
Group type: EXPERIMENTAL
Intervention: Body mass index (BMI)
Number of subjects: 881
Study 37828071 — intervention group
Group type: EXPERIMENTAL
Intervention: LDL < 100 mg/dl
Number of subjects: 881
Study 37828071 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of statins
Number of subjects: 881
Study 37828071 — intervention group
Group type: EXPERIMENTAL
Intervention: HbA1c ≤ 6.5
Number of subjects: 881
Study 37828470 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical assessment, chest X-ray, and comprehensive lung function assessment at treatment completion and again six and 12 months later.
Number of subjects: 80
Study 37828487 — intervention group
Group type: EXPERIMENTAL
Intervention: Music Breathing program (6 weeks, includes music listening and mindful breathing)
Number of subjects: 290
Study 37828487 — intervention group
Group type: COMPARATOR
Intervention: Mental Health Education Programme (6 weeks)
Number of subjects: 290
Study 37828487 — intervention group
Group type: EXPERIMENTAL
Intervention: Music Breathing program
Number of subjects: 290
Study 37828487 — intervention group
Group type: COMPARATOR
Intervention: Mental Health Education Programme
Number of subjects: 290
Study 37828493 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate or severe unipolar depressive episode with at least passive suicidal thoughts
Number of subjects: 4500
Study 37828493 — intervention group
Group type: EXPERIMENTAL
Intervention: Suicidality assessment using the Sheehan-Suicide Tracking Scale (S-STS)
Number of subjects: 4500
Study 37828493 — intervention group
Group type: EXPERIMENTAL
Intervention: Exploratory objectives regarding suicidality
Number of subjects: 4500
Study 37828493 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured assessments of factors influencing self-injurious behavior
Number of subjects: 4500
Study 37828503 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower parent income
Number of subjects: 452
Study 37828503 — intervention group
Group type: EXPERIMENTAL
Intervention: Medicaid status
Number of subjects: 452
Study 37828503 — intervention group
Group type: COMPARATOR
Intervention: Child delay discounting
Number of subjects: 452
Study 37828564 — intervention group
Group type: EXPERIMENTAL
Intervention: Group Physical Therapy Program for Knee OA (Group PT) with tailored, high-touch support (enREP)
Number of subjects: 16
Study 37828564 — intervention group
Group type: COMPARATOR
Intervention: Group Physical Therapy Program for Knee OA (Group PT) with standard, low-touch support (REP)
Number of subjects: 16
Study 37828564 — intervention group
Group type: EXPERIMENTAL
Intervention: Implementation outcomes (penetration, adoption, fidelity)
Number of subjects: 16
Study 37828564 — intervention group
Group type: EXPERIMENTAL
Intervention: Staffing and labor costs
Number of subjects: 16
Study 37828585 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 M™ Coban™ elastic bandage for 48 h
Number of subjects: 360
Study 37828585 — intervention group
Group type: COMPARATOR
Intervention: 3 M™ Coban™ elastic bandage for the first 24 h and then a class II compression full-length stocking (23-32 mm Hg) for 1 week
Number of subjects: 360
Study 37828596 — intervention group
Group type: EXPERIMENTAL
Intervention: Text message reminder (TMR)
Number of subjects: 1180
Study 37828596 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational interviewing (MI)
Number of subjects: 1180
Study 37828596 — intervention group
Group type: EXPERIMENTAL
Intervention: TMR plus MI
Number of subjects: 1180
Study 37828596 — intervention group
Group type: COMPARATOR
Intervention: Enhanced usual care
Number of subjects: 1180
Study 37828618 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced therapy (personalized treatment approach including pressure-optimized custom-made footwear, at-home daily foot temperature monitoring, structured education)
Number of subjects: 126
Study 37828618 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 126
Study 37829600 — intervention group
Group type: EXPERIMENTAL
Intervention: Pfannenstiel skin incision adjusted according to the fetal head's occipitofrontal diameter (OFD)
Number of subjects: 114
Study 37829689 — intervention group
Group type: EXPERIMENTAL
Intervention: Radial artery grafts (RA-CABG)
Number of subjects: 370
Study 37829712 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise intervention (25 supervised endurance exercise sessions with moderate or high intensity for 8 weeks)
Number of subjects: 62
Study 37829712 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise intervention
Number of subjects: 62
Study 37829712 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercise intervention)
Number of subjects: 62
Study 37830208 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 6263
Study 37830208 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6263
Study 37830268 — intervention group
Group type: EXPERIMENTAL
Intervention: CURE (Circumferential URE)
Number of subjects: 450
Study 37830268 — intervention group
Group type: EXPERIMENTAL
Intervention: RURE (Radial URE)
Number of subjects: 450
Study 37830268 — intervention group
Group type: EXPERIMENTAL
Intervention: CURE and RURE
Number of subjects: 450
Study 37830268 — intervention group
Group type: EXPERIMENTAL
Intervention: UREs (CURE and RURE)
Number of subjects: 450
Study 37830329 — intervention group
Group type: EXPERIMENTAL
Intervention: Real-time feedback on CPR performance
Number of subjects: 0
Study 37830329 — intervention group
Group type: COMPARATOR
Intervention: No feedback on CPR performance
Number of subjects: 0
Study 37830338 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate Intensity Exercise Training (MIT) for 5 months
Number of subjects: 0
Study 37830338 — intervention group
Group type: EXPERIMENTAL
Intervention: High Intensity Training (HIT) for 4 months after 1 month of MIT
Number of subjects: 0
Study 37830338 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 37830342 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenecteplase, 0.4 mg/kg
Number of subjects: 483
Study 37830342 — intervention group
Group type: COMPARATOR
Intervention: Alteplase, 0.9 mg/kg
Number of subjects: 483
Study 37830344 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose aspirin
Number of subjects: 13815
Study 37830344 — intervention group
Group type: COMPARATOR
Intervention: Low-dose aspirin
Number of subjects: 13815
Study 37830451 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (RRMS patients experiencing relapses)
Number of subjects: 1008
Study 37830451 — intervention group
Group type: EXPERIMENTAL
Intervention: Relapse severity (associated factor)
Number of subjects: 1008
Study 37830579 — intervention group
Group type: EXPERIMENTAL
Intervention: Mitazalimab (600 µg/kg and 900 µg/kg administered intravenously)
Number of subjects: 0
Study 37830895 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital breast tomosynthesis (TM)
Number of subjects: 136742
Study 37830895 — intervention group
Group type: COMPARATOR
Intervention: Digital mammography (DM)
Number of subjects: 136742
Study 37830895 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality control (QC) testing
Number of subjects: 136742
Study 37830908 — intervention group
Group type: EXPERIMENTAL
Intervention: mRNA-1273 (Moderna) or BNT162b2 (Pfizer-BioNTech) SARS-CoV-2 vaccine
Number of subjects: 439
Study 37830944 — intervention group
Group type: EXPERIMENTAL
Intervention: Local resection (LR)
Number of subjects: 183
Study 37830944 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive surgery (MIS)
Number of subjects: 183